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Blockade of BFA-mediated apoptosis in macrophages
by the HIV-1 Nef protein
W Abbas1, KA Khan1, A Kumar1, MK Tripathy1, I Dichamp1, M Keita1, U Mahlknecht2, O Rohr3 and G Herbein*,1
HIV-1 Nef protein has key roles at almost all stages of the viral life cycle. We assessed the role of Nef and of the translation
elongation factor eEF1A in primary human macrophages. Nuclear retention experiments and inhibition of the exportin-t (Exp-t)
pathway suggested that cytoplasmic relocalization of eEF1A, mediated by Exp-t occurs in Nef-treated monocyte-derived
macrophages (MDMs). We observed the presence of tRNA in the Nef/eEF1A complexes. Nucleocytoplasmic relocalization of the
Nef/eEF1A complexes prevented stress-induced apoptosis of MDMs treated with brefeldin A. Blockade of stress-induced
apoptosis of MDMs treated with HIV-1 Nef resulted from enhanced nucleocytoplasmic transport of eEF1A with decreased release
of mitochondrial cytochrome c, and from increased tRNA binding to cytochrome c, ultimately leading to an inhibition of caspase
activation. Our results indicate that HIV-1 Nef, through the nucleocytoplasmic relocalization of eEF1A and tRNAs, enhances
resistance to stress-induced apoptosis in primary human macrophages.
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The endoplasmic reticulum (ER) is a well-orchestrated
protein-folding machine composed of protein chaperones,
proteins that catalyze protein folding, and sensors that detect
the presence of misfolded or unfolded proteins. The unfolded
protein response (UPR) is an intracellular signaling pathway
that coordinates the ER protein-folding demand with protein-
folding capacity and is essential to adapt to homeostatic
alterations that cause protein misfolding.1 Accumulating
evidence suggests that protein folding and generation of
reactive oxygen species (ROS) as a byproduct of protein
oxidation in the ER are closely linked events. It has also
become apparent that activation of the UPR on exposure to
oxidative stress is an adaptive mechanism to preserve cell
function and survival.1 Persistent oxidative stress and protein
misfolding initiate apoptotic cascades and are now known to
have predominant roles in the pathogenesis of multiple human
diseases including diabetes, atherosclerosis, and neuro-
degenerative diseases.2
Activated monocytes are a major source of ROS that are
essential for bacterial killing.3 However, excessive ROS
production not appropriately compensated by antioxidant
molecules can lead to oxidative stress, which may also have
an important role in pathogenesis of HIV infection through
various mechanisms.4 ROS participate in T-lymphocyte
depletion by triggering apoptosis; and monocytes can also
induce their own apoptosis by producing ROS.5 HIV infection
leads to the production of ROS in infected cells and causes
transient downregulation of the antiapoptotic Bcl-2 and
thioredoxin (TRX) protein expression in Jurkat and U937
cells, followed by restoration to initial levels. Cells with
decreased levels of these proteins are susceptible to
apoptosis.4 In addition, the upregulation of Bcl-2 expression
represses HIV replication; therefore, the state of low level viral
replication may be favorable for cell survival, resulting in
persistent infection.6 In monocytes, from asymptomatic
patients, the levels of Bcl-2 and TRX decrease, which is
associated with enhanced hydrogen peroxide production,
whereas in cells from AIDS patients the levels returned to
normal.6 Thus, the redox balance affected by the intracellular
TRX system seems to be important for cell survival and low
viral production, probably leading to chronic persistent
infection of HIV. HIV-1Tat has been reported to induce
UPR,7 indicating that ER stress response could be a critical
parameter to control during HIV infection.
Nuclear–cytoplasmic transport of all molecules, such as
proteins and RNA species, across the nuclear envelope occur
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through the channels formed by macromolecular structures
known as nuclear pore complexes. The translation elongation
factor EF1A has been described as a cytoplasmic component
of the nuclear aminoacylation-dependent tRNA export path-
way.8 eEF1A interacts directly with aminoacylated tRNAs.
Exp-t has been reported to have a major role in eEF1A-
mediated export, though Exp-5, which preferentially exports
pre-miRNAs, has been reported to be involved in the nuclear–
cytoplasmic transport of tRNAs in some cases.9 In addition to
the conventional role of eEF1A during protein synthesis,
namely GTP-dependent binding and transport of aminoacyl-
tRNA to the A site of the ribosome, eEF1A has a role in the
cytoplasm. One of the proposed unconventional functions of
eEF1A is a role in the regulation of cytoskeletal dynamics.10
In addition to binding GDP/GTP, aminoacyl-tRNA, EF1b, and
the ribosome, eEF1A binds and bundles actin and binds
microtubules. Because eEF1A is an abundant protein in most
eukaryotic cells and binds to actin filaments with relatively high
affinity, it could be a potent regulator of the cytoskeleton.11
Previous in vitro studies demonstrated that eEF1A inhibits
the rate of actin polymerization and stabilizes actin
filaments.12
In addition, eEF1A has been reported to have a role in
apoptosis or programmed cell death. Early experiments
showed that the level of eEF1A expression in cultured mouse
fibroblasts correlates with the rate of apoptosis on serum
withdrawal, with higher levels of eEF1A expression asso-
ciated with a faster rate of cell death.13 Other studies have
indicated that eEF1A prevents cell death; and numerous
studies have shown that eEF1A expression increases in
tumor cells and tumor tissues parallel with decreased
caspase-3 activation.14,15
Nef, a 27-kDa HIV-1 protein, is translated from multiply
spliced viral mRNAs early during infection.16 Endogenous Nef
may have evolved a number of different, independent
functional activities to enhance the replication and survival
of the virus within infected cells and to facilitate its spread
in vivo.17 Nef enhances virion infectivity and increases viral
replication in primary lymphocytes and macrophages.18 The
protein can also mediate downregulation of CD4 cell surface
expression, a phenomenon important for the release of HIV-1
from the infected cell.17 In addition, Nef can downregulate the
cell surface expression of major histocompatibility complex
class I (MHC-I) molecules, an effect found to protect infected
cells from cytotoxic T cells.19 The Nef protein prevents
apoptosis of HIV-1-infected T cells through either interference
with Fas/TNFa receptor death-signaling pathways by
inhibiting apoptosis signal-regulating kinase 1 (ASK-1)20 or the
formation of a complex with both p21-activated kinase (PAK)
and phosphatidylinositol-3 kinase (PI3K), which increases
phosphorylation and inactivation of the pro-apoptotic Bad
protein.21 HIV-1 Nef protects human monocyte-derived
macrophages (MDMs) from HIV-1-induced apoptosis, and
this protection correlates with the hyperphosphorylation and
consequent inactivation of Bad.22 Nef expression within
macrophages has been reported to favor the recruitment of
resting T cells via the secretion of C–C chemokines and to
subsequently favor their activation, suggesting a role for Nef in
lymphocyte recruitment and activation at sites of viral
replication.23
Our results indicate that HIV-1 Nef associates with eEF1A
and that Exp-t contributes to the nuclear–cytoplasmic trans-
port of Nef/eEF1A/tRNA complexes in macrophages. Finally,
we observed that cytoplasmic relocalization of the Nef/
eEF1A/tRNA complexes prevents stress-induced apoptosis
in macrophages via increased cytoplasmic eEF1A expres-
sion, decreased release of mitochondrial cytochrome c, and
plugging of released cytochrome c by cytoplasmic tRNAs,
ultimately resulting in decreased caspase activation.
Results
Interaction between HIV-1 Nef and eEF1A. As both Nef
and eEF1A modulate apoptosis,14,22 we assessed whether
eEF1A is part of a eEF1A/Nef complex. To test this
interaction, we expressed a Nef–GST fusion protein in
E. coli and tested its ability to interact with eEF1A from
U937 cell lysates. The Nef protein bound to eEF1A
(Figure 1a). Endogenous eEF1A protein present in the
lysates of Vero cells, MRC5 cells, promonocytic U937 cells,
primary peripheral blood lymphocytes (PBLs), and primary
MDMs co-immunoprecipitated with recombinant Nef (rNef)
added to the culture, whereas the isotype control showed
no associated eEF1A protein on immunoprecipitation
(Figure 1b). The interaction between eEF1A and rNef was
detected in both nuclear and cytoplasmic lysates prepared
from the cells (Figure 1b).
The interaction between eEF1A and endogenous Nef was
also demonstrated by transient transfection of U937 cells with
a nef-expressing plasmid (Figure 1c), and in peripheral blood
Figure 1 eEF1A interacts with HIV-1 Nef protein in vitro and in vivo. (a) Binding of HIV-1 Nef to eEF1A was measured in GST pull-down assays using U937 cells as a
source of lysates. b-actin detection represents input loading controls of the lysates that were used in binding reactions. Results are representative of three independent
experiments. The right panel represents coomassie staining of expressed proteins that were used in the binding reaction of GST pull-down. (b) Cytoplasmic and nuclear
extracts from several cell lines (Vero, MRC5, and U937 cells), PBLs, and MDMs treated with rNef (100 ng/ml) for 0.5 h were immunoprecipitated with an anti-eEF1A antibody,
or Nef (100 ng/ml)-treated total cellular lysates were immunoprecipitated with an isotype control antibody. Immunoprecipitated material was analyzed by western blotting with
an anti-Nef monoclonal antibody. Recombinant Nef-treated total cell lysates were used as a positive control. Results are representative of three independent experiments.
(c) Cellular extracts of U937 cells transfected for 48 h with a nef-expressing plasmid (pNef) were immunoprecipitated with an anti-eEF1A antibody, anti-Nef antibody, or isotype
control antibody. Immunoprecipitated material was analyzed by western blotting with an anti-Nef monoclonal antibody. Results are representative of two independent
experiments. (d) Cellular extracts of PBMCs infected in vitro with HIV-189.6 or mock infected were immunoprecipitated with an anti-eEF1A antibody or anti-Nef monoclonal
antibody. Immunoprecipitated material was analyzed by western blotting with an anti-Nef monoclonal antibody or anti-eEF1A antibody. Results are representative of two
independent experiments. (e and f) eEF1A and HIV-1 Nef interact in vitro in a mammalian two-hybrid assay. (e) Schematic representation of expression constructs used in co-
transfection experiments in the mammalian two-hybrid model. (f) Mammalian two-hybrid analysis with eEF1A fused to the VP16 activator domain and HIV-1 Nef fused to the
GAL4 domain. Luciferase assays were conducted on total extracts from U937 cells transfected with the luciferase expression construct pG5-Luc, pBIND-Nef, pACT-eEF1A, or
control plasmids. As a positive control, two plasmids, pACT-MyoD and pBIND-Id, were co-transfected, and co-transfection of empty vectors was used as a negative control.
Results represent the mean of three independent experiments. ***Po0.001
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mononuclear cells (PBMCs) infected in vitro with HIV-189.6
(Figure 1d). Thus, eEF1A interacts with the Nef protein, not
only in vitro within several cell types treated with rNef but also
with the endogenous Nef protein produced within HIV-1-
infected primary PBMCs. Lysates from MDMs treated with
rNef in vitro were immunoprecipitated with antibodies directed
against the eukaryotic translation elongation factor-2 (eEF2),
and western blot performed with an anti-Nef antibody. The Nef
protein did interact with eEF1A, but not with eEF2 (data not
shown), indicating that the Nef/eEF1A interaction was
specific. We further investigated the interaction between
eEF1A and Nef using a mammalian two-hybrid assay. Nef
fused to the GAL4 DNA-binding domain (pBIND) was used as
the bait vector, and eEF1A fused to the VP16-activation
domain (pACT) was used as the prey vector (Figure 1e). The
constructs were transfected into mammalian cells along with
the pG5-Luc vector, which contains five GAL4-binding sites
upstream of a minimal TATA box upstream of the luciferase
gene. The interaction between the GAL4-Nef and VP16-
eEF1A fusion constructs resulted in an 18-fold increase of
relative luciferase expression over the negative control (1847
versus 105 relative light units (r.l.u.); Figure 1f). Expression of
pGAL4-Nef alone or pVP16- eEF1A alone did not result in
increased luciferase activity compared with negative controls
(115 r.l.u. and 103 r.l.u., respectively).
Determination of eEF1A and HIV-1 Nef regions involved
in eEF1A–Nef interaction. To determine the region of
eEF1A responsible for association with HIV-1 Nef, we used
deletion mutants engineered within the cDNA encoding
eEF1A.24 Lysates from bacteria expressing N-terminal HA-
tagged eEF1A mutants were used in binding reactions with
GST-HIV-1 Nef. The deletion mutants we analyzed are
shown in Figure 2a. Three of the deletion mutants were not
stably expressed.24 Of the deletion mutants that were
expressed, only the eEF1A 1-74 mutant was capable of
binding Nef (Figure 2a). These results demonstrate that the
eEF1A fragment encoding the N-terminal 74 amino acids is
sufficient for HIV-1 Nef binding. To determine the region of
HIV-1 Nef responsible for binding to eEF1A, two GST-Nef
deletion mutants (N-terminus, GST-Nef1-60; C-terminus,
GST-Nef55-206) were produced and assayed for their ability
to associate with eEF1A in vitro (Figure 2b). The GST-Nef1-
60 and GST-Nef55-206 mutants had intact N-terminal and
C-terminal sequences (data not shown). Lysates from MDMs
were used in binding reactions with GST-HIV-1 Nef
constructs. Of the three GST–Nef constructs, only GST-
NefWT and GST-Nef55-206 were capable of binding eEF1A
(Figure 2b). These results demonstrate that the N-terminus
of Nef is not required for eEF1A binding, and that the Nef
fragment encoding amino acids 55–206 is sufficient.
Cytoplasmic relocalization of eEF1A by HIV-1 Nef is
mediated by Exp-t. The eEF1A protein is found in both the
nucleus and cytoplasm of cells, which favors the nuclear
export of mature tRNAs. In the absence of Nef, we observed
relatively more eEF1A in the nucleus than the cytoplasm of
primary MDMs (Figure 3a, mock). To determine whether
Nef, via its interaction with eEF1A, interferes with the
nuclear–cytoplasmic distribution of eEF1A, we treated
MDMs with rNef.25 Nuclear and cytoplasmic extracts were
prepared from cells treated up to 12 h with rNef, and eEF1A,
Exp-t and rNef were assessed in both cellular compartments.
rNef enhanced the nuclear–cytoplasmic transport of eEF1A
up to 12 h post treatment in MDMs (Figure 3a). Our results
indicate that rNef could actively favor the nuclear export of
eEF1A in MDMs.
We tested several exportins, Exp-t, Exp-1, and Exp-5, in
regard to the nuclear–cytoplasmic transport of eEF1A in the
presence of rNef. Using MDM lysates, we detected a direct
interaction between GST-Nef and Exp-t using a pull-down
assay (Figure 3b). No direct interaction between GST-Nef and
Exp-1 was observed (data not shown). Using lysates from
untreated MDMs, we detected an interaction between eEF1A
and Exp-t by co-immunoprecipitation (Figure 3c). We did not
detect any interaction between eEF1A and Exp-1 in untreated
MDMs (data not shown). Confirming a potential interaction
between Exp-t, eEF1A and Nef, we observed an increase in
eEF1A and Exp-t in the cytoplasmic extracts from MDMs
treated with rNef as early as 30 min post treatment
(Figure 3a). A sustained presence of rNef and eEF1A was
detected in the cytoplasm of rNef-treated MDMs up to 12 h
post treatment (Figure 3a). To determine the role of Exp-t in
the nuclear–cytoplasmic transport of rNef/eEF1A complexes,
MDMs were transfected with Exp-t siRNA 48 h before
treatment with rNef. Knockdown of the Exp-t protein in MDMs
was monitored by western blot (Figure 3d). Knockdown of
Exp-t resulted in enhanced nuclear retention of eEF1A and
rNef in MDM cultures treated with rNef (Figure 3e). We did not
detect any nuclear retention of rNef or eEF1A following
treatment of MDMs with the Exp-1 inhibitor leptomycin B or
Exp-5 siRNA (data not shown). Our results indicate that, in
rNef-treated MDMs, the nuclear–cytoplasmic transport of
rNef/eEF1A complexes is preferentially mediated by Exp-t.
Nuclear–cytoplasmic relocalization of eEF1A by rNef
blocks stress-induced apoptosis in macrophages.
Brefeldin A (BFA) disrupts the organization of the microtubule
and actin cytoskeleton and exerts ER and Golgi stress,
resulting in apoptosis (Supplementary Figure 1). Interest-
ingly, eEF1A is an actin/microtubule-binding protein and
could interfere with BFA-induced apoptosis. Therefore, we
examined whether nuclear–cytoplasmic transport of eEF1A
by rNef inhibits BFA-induced apoptosis in MDMs, potentially
due to cytoplasmic accumulation of eEF1A. We observed
that pretreatment with rNef inhibits BFA-induced apoptosis in
MDMs in a dose-dependent manner (Figure 4a). In addition,
pretreatment with rNef did not inhibit apoptosis induced by
tunicamycin (TM) or thapsigargin (TG) that disturb protein
glycosylation or Ca2þ signaling, respectively (Figure 4b).
Of the three Nef proteins, only NefWT and Nef55-206
were capable of blocking BFA-induced apoptosis in MDMs
(Figure 4c).
Because Exp-t is involved in nuclear–cytoplasmic trans-
portation of the eEF1A/rNef complexes, we assessed
apoptosis among MDMs treated with rNef before BFA
treatment and transfected with siRNA Exp-t, siRNA Exp-1,
siRNA Exp-5, or a scrambled control. We observed that
transfection with siRNA Exp-t, but not siRNA Exp-1 or siRNA
Exp-5, inhibited the rNef-mediated blockade of apoptosis in
Nef blocks stress-mediated apoptosis in macrophages
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MDMs treated with BFA (Figure 4d). Furthermore, the
knockdown of eEF1A by siRNA inhibited the Nef-mediated
blockade of apoptosis in MDMs treated with BFA (Figure 4e).
Our results indicate that Exp-t-mediated nuclear–cytoplasmic
transport of the rNef/eEF1A complexes in MDMs is involved in
the inhibition of apoptosis triggered by stress, such as BFA
treatment.
As shown in Figure 5a, p35 pro-caspase-3 is diminished
and cleaved to p20/p17 proteins in MDMs treated with BFA,
confirming that BFA-induced apoptosis activates caspase-
3.26,27 Under ER stress treatments, such as BFA, the
magnitude of protection against apoptosis directly correlates
with the level of cytoplasmic eEF1A expression;28,29 there-
fore, we measured the levels of eEF1A in the cytosol of BFA-
stimulated MDMs treated with increasing concentrations of
Nef. We observed that the levels of cytosolic eEF1A positively
correlated with Nef treatment in a dose-dependent manner, as
well as with the resistance to apoptosis in BFA-stimulated
MDMs as measured by decreased caspase-3 activation and
cytochrome c release (Figure 5b).
Cytoplasmic extracts of BFA-stimulated MDMs treated with
rNef, in the absence or presence of Exp-t siRNA, Exp-1
siRNA, or Exp-5 siRNA, were analyzed for caspase-3
activation. Exp-t, Exp-1, and Exp-5 knockdown in MDMs
was monitored by western blot (Figures 3d and 5c). Knock-
down of Exp-t, but not Exp-1 or Exp-5, relieved the Nef-
mediated blockade of apoptosis in BFA-stimulated MDMs
(Figure 5d). Relief of the Nef-mediated blockade of apoptosis
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Figure 4 rNef-mediated inhibition of BFA-induced apoptosis in MDMs parallels cytoplasmic accumulation of eEF1A and is dependent on Exp-t. (a) rNef prevents BFA-
induced apoptosis in MDMs. MDMs were treated with BFA (10mg/ml) for 12 or 15 h or left untreated in the presence of increasing concentrations of rNef (0, 125, 750 ng/ml).
Apoptosis was detected by annexin-V flow cytometric analysis. The histogram summarizes the survival of MDMs following treatment with BFA (10 mg/ml) for 12 or 15 h in the
presence of increasing concentrations of rNef. The results represent means of three independent experiments. *Po0.05. (b) rNef prevents BFA-induced apoptosis, but
neither TM-induced apoptosis nor TG-induced apoptosis in MDMs. MDMs were treated with BFA (10mg/ml), TM (10 mg/ml) or TG (10mg/ml) for 5 or 12 h or left untreated in
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Results are representative of data observed in two independent experiments. (d) Blockade of BFA-induced apoptosis in MDMs by rNef is dependent on Exp-t. MDM cultures
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or BFAþNef in the presence of exportin siRNAs. Results are representative of three independent experiments. *Po0.05. (e) Blockage of BFA-induced apoptosis in MDMs by
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(1mg/ml) or absence of rNef. Apoptosis was measured by the TUNEL assay. Results are representative of two independent experiments. EF1A knockdown in MDMs was
monitored by western blot (upper right panel). The histogram shows the percentage of TdT positive cells
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in BFA-stimulated MDMs transfected with Exp-t siRNA was
accompanied by decreased cytoplasmic eEF1A (Figure 5d).
Our results indicate a critical role for Exp-t and eEF1A in
resistance to apoptosis in BFA-treated MDMs.
Cytochrome c-induced caspase-9 activation is regulated at
multiple levels, and tRNA was reported recently to bind to
cytochrome c, blocking formation of the apoptosome and the
subsequent activation of caspase-9.30 Therefore, we tested
whether Nef can prevent cytochrome c release in the
cytoplasm. We found that most of the cytochrome c was
detected in the mitochondrial fraction from normal MDMs,
whereas the majority of the cytochrome c in BFA-treated
MDMs was detected in the cytosolic fraction (Figure 5e).
In Nef-treated MDMs, most of the cytochrome c was detected
in the mitochondrial fractions, even after BFA stimulation,
which suggests that mitochondrial cytochrome c release is
blocked by Nef treatment (Figure 5e).
As shown in Figure 5f, cleavage of 45-kDa procaspase-9 to
a 35-kDa fragment in MDMs treated with BFA was blocked by
Nef, but not by inactivated boiled Nef, confirming that BFA-
induced apoptosis activates caspase-9 and that it can be
inhibited by Nef. The processing of caspase-9 induced by BFA
in Nef-treated MDMs was inhibited in a dose-dependent
manner (Figure 5g), indicating that Nef may function by
preventing the activation of caspase-9 via decreased release
of mitochondrial cytochrome c. As shown in Figure 5h,
pretreatment with rNef did not inhibit the processing of
caspase-3 and caspase-9 induced by TM or TG.
eEF1A/Nef complexes contain tRNAs and block stress-
induced apoptosis in MDMs through tRNA binding to
cytochrome c. As both eEF1A and HIV-1 Nef bind to tRNAs
preferentially,31 we specifically assessed the presence of
several tRNAs in the rNef/eEF1A complexes in MDMs
treated with rNef. MDMs treated with rNef were lysed and
the presence of tRNAs in the immunoprecipitated eEF1A/
rNef complexes was analyzed using RT-PCR. We detected
the presence of all tested tRNAs, namely tRNAMet,
tRNAPhe, tRNATrp, and tRNALys in the eEF1A/rNef
complexes in MDMs (Figures 6a, c and d). Furthermore,
the knockdown of eEF1A by siRNA resulted in the partial
inhibition of tRNA binding to cytochrome c (Figure 6b). The
DDCt values were determined separately for untreated cells
and averaged around 1 (Supplementary Figure 2).
The binding of tRNAs to cytochrome c was recently
reported to inhibit caspase-9 activation. Therefore, we
hypothesized that the enhanced nuclear–cytoplasmic trans-
port of eEF1A/rNef/tRNA complexes mediated by Exp-t might
result in higher levels of cytosolic tRNAs, which could target
cytochrome c released in BFA-treated MDMs. Cytoplasmic
extracts of MDMs treated with increasing amounts of rNef
were tested for the presence of tRNAs complexed with
immunoprecipitated eEF1A and cytochrome c. We observed
that tRNA binds to eEF1A in the cytosol of BFA-treated MDMs
in a Nef-dependent manner (Figure 6e). Similar results were
obtained for the binding of tRNA to cytochrome c (Figure 6f),
indicating that Nef treatment of BFA-stimulated MDMs favors
the formation of tRNA/cytochrome c complexes in the
cytoplasm. Cytoplasmic extracts of BFA-stimulated MDMs
treated with rNef, in the absence or presence of Exp-t siRNA,
Exp-1 siRNA, or Exp-5 siRNA, were analyzed for the
presence of tRNA binding cytochrome c. Knockdown of
Exp-t, but not Exp-1 or Exp-5, decreased the amount of tRNAs
that bound to cytochrome c, as well as eEF1A, in BFA-
stimulated MDMs treated with Nef (Figures 6g and h).
Similarly, the knockdown of eEF1A by siRNA decreased the
amount of tRNAs that were associated with cytochrome c in
BFA-stimulated MDMs treated with Nef (Figure 6i).
Discussion
We observed a direct interaction between HIV-1 Nef and
eEF1A. In rNef-treated MDMs, the rNef-mediated nuclear–
cytoplasmic relocalization of eEF1A was dependent on Exp-t.
We also report the specific presence of tRNAs in the
rNef/eEF1A complexes. Nuclear–cytoplasmic relocalization
of rNef/eEF1A/tRNA prevented stress-induced apoptosis
of MDMs treated with BFA through decreased release of
mitochondrial cytochrome c, enhanced tRNA binding to
release cytosolic cytochrome c, and increased cytoplasmic
levels of eEF1A, ultimately resulting in decreased caspase
activation (Figure 7). Our results indicate that the HIV-1 Nef
protein enhances resistance to stress-induced apoptosis in
MDMs through the nuclear–cytoplasmic relocalization of rNef/
eEF1A/tRNA complexes.
Our results show that nuclear–cytoplasmic transport
of eEF1A/Exp-t/tRNA complexes occurs in MDMs
treated with rNef. Although the role of eEF1A in tRNA
transport has been reported, this is the first time that a viral
protein such as Nef has been shown to be actively involved in
such a process. The presence of relatively more amounts of
eEF1A in the nucleus of MDMs confirms previous results
indicating that eEF1A is localized in both the cytoplasm
and nucleus of cells. We also observed that the nuclear–
cytoplasmic distribution of eEF1A/rNef complexes included the
presence of RNA (Figures 6a–d). Both proteins most
probably bind to each other in an RNA-independent manner.
First, we observed the interaction between Nef and eEF1A in
a purified system (Figure 2a). Second, supportive
experimental evidence comes from crosslinking studies
between rabbit EF-1a GTP and aminoacyl-tRNA that indicate
contact sites corresponding to residues 270–275, 345–355
and 375, sites that are in contact with the RNA in the ternary
complex crystal.32 Finally, the N-terminal Arg-rich region of
HIV-1 Nef (aa 1–22) binds to RNA in vitro.31 As the Nef
fragment encoding amino acids 55–206 is sufficient for
binding to the N-terminal extremity of eEF1A (Figure 2b), it
is highly unlikely that the Nef interaction with eEF1A requires
the presence of RNA.
We hypothesized that tRNA is the most likely candidate to
be present in the Nef–eEF1A complex because eEF1A binds
to aminoacyl-tRNA during translation and Nef has been
shown to bind to tRNAs and promote the annealing of primer
tRNA to viral genomic RNA. In addition, Exp-t, rather than
Exp-5, has a critical role in this process, which is in agreement
with a critical role of Exp-t in the selection and transport of
mature tRNAs from the nucleus to the cytoplasm.
Nef has been reported to prevent both Fas and TNF
receptor-mediated deaths in HIV-infected T cells via interac-
tion with ASK-1, thereby blocking the extrinsic apoptosis
Nef blocks stress-mediated apoptosis in macrophages
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pathway. Nef inhibits ASK-1, caspase-3, and caspase-8
activation, resulting in the blockade of apoptosis in HIV-
infected cells. Nef has also been shown to block the intrinsic
apoptosis pathway via inhibition of the pro-apoptotic protein
Bad.33 Our data highlight a new molecular mechanism elicited
by the HIV-1 Nef protein to block the intrinsic apoptosis
pathway in Nef-expressing cells, such as HIV-1-infected
MDMs. The HIV-1 Nef protein, through the nuclear–
cytoplasmic relocalization of rNef/eEF1A/tRNA complexes,
could participate in preventing stress-mediated effects at
several levels. First, the decreased cytochrome c release is
probably due to cytoplasmic accumulation of eEF1A that
stabilizes actin filaments and potentially could block the BFA-
induced disruption of the organization of the microtubule and
actin cytoskeleton. Second, the tRNAs could be specifically
delivered by the eEF1A/Nef/tRNA complexes to cytosolic
cytochrome c, thereby preventing cytochrome c interaction
with Apaf-1 and blocking caspase activation and apoptosis.
Third, the eEF1A protein could be delivered by the eEF1A/
Nef/tRNA complexes in the cytoplasm to participate in
cytoskeleton rearrangement aimed to eliminate unfolded
proteins produced during stress events.34–36 Finally, eEF1A
has been reported to activate Akt, the protein kinase B
reported by numerous studies to favor resistance to apoptosis.11
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Figure 5 rNef-mediated cytoplasmic accumulation of eEF1A in BFA-treated MDMs inhibits caspase activation and decreases the cytoplasmic release of cytochrome c.
(a) Inhibition of caspase-3 activation in BFA-stimulated MDMs treated with rNef (1000 ng/ml). (b) Inhibition of caspase-3 activation in BFA-stimulated MDMs treated with rNef is
dose-dependent. Mitochondrial cytochrome c release in BFA-treated MDMs is blocked by rNef in a dose-dependent manner and positively correlates with cytoplasmic
accumulation of eEF1A. (c) Knockdown of Exp-1 and Exp-5 proteins by siRNA in MDMs. MDM cultures were transfected with a scrambled control, Exp-1 siRNA, or Exp-5
siRNA. Total cellular extracts were prepared 48 h post transfection. Protein expression was analyzed by western blot. b-actin was used as a loading control. (d) Inhibition of
caspase-3 activation in BFA-stimulated MDMs treated with rNef is dependent on Exp-t. (e) Mitochondrial cytochrome c release in BFA-treated MDMs is blocked by rNef.
(f) Inhibition of caspase-9 activation in BFA-stimulated MDMs treated with rNef (1000 ng/ml). Protein levels of caspase-9 were quantified by densitometry using ImageJ 1.40
software (the level of caspase-9 in mock cells was arbitrarily established at 1). (g) Inhibition of caspase-9 activation in BFA-stimulated MDMs treated with rNef is dose-
dependent. Protein levels of caspase-9 were quantified by densitometry using ImageJ 1.40 software (the level of caspase-9 in mock cells was arbitrarily established at 1).
(h) Inhibition of caspase activation in BFA-stimulated MDMs treated with rNef, but neither in TM-stimulated MDMs nor in TG-stimulated MDMs treated with rNef. Left panel:
time–course of caspase activation in BFA-stimulated MDMs, TM-stimulated MDMs or TG-stimulated MDMs. Right panel: inhibition of caspase activation in BFA-stimulated
MDMs treated with rNef, but neither in TM-stimulated MDMs nor in TG-stimulated MDMs treated with rNef. MDM cultures were treated with BFA (10mg/ml), TM (10mg/ml), or
TG (10mg/ml) for 12 h in the presence of rNef (1 mg/ml), and caspase-3 and -9 activation was measured in total cellular lysates. Results are representative of data obtained in
three independent experiments
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In order to determine the scope of eEF1A-mediated
protection, we assayed eEF1A antiapoptotic activity in
response to ER stress agents, BFA, TM and TG. BFA
reversibly blocks protein transport between the ER and Golgi,
whereas TM blocks the synthesis of all N-linked glycoproteins
(N-glycans)37 and TG inhibits the ER Ca2þ -ATPase family of
calcium pumps.38 Our results indicate that Nef specifically
blocks apoptosis induced by the ER-stress agent BFA,
indicating that increased cytoplasmic relocalization of eEF1A
by HIV-1 Nef may alleviate the inhibition of protein transport
between the ER and Golgi observed in BFA-treated cells.
In addition, Nef could favor an homeostatic control of UPR and
of oxidative stress observed during the acute phase of HIV
infection and subsequently fuel the progression of the disease
toward a chronic infection with the formation of cellular
reservoirs of the virus.
Taken together, the results indicate that cytoplasmic
relocalization of the eEF1A/tRNAs complexes by HIV-1 Nef
could ultimately favor the survival of the cell under stress,
thereby allowing optimal viral replication. This event may
participate in the formation and maintenance of viral reser-
voirs in HIV-infected persons.
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Figure 7 Potential inhibitory effect of the eEF1A/rNef/tRNA complex on the intrinsic apoptotic pathway in BFA-treated MDMs. HIV-1 Nef protein favors translocation and
accumulation of eEF1A from the nucleus toward the cytoplasm of the cell. tRNA is present in the Nef/eEF1A complex that is exported by Exp-t and buffers the cytochrome
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Figure 6 rNef-mediated cytoplasmic accumulation of eEF1A in BFA-treated MDMs parallels tRNA binding to cytochrome c. (a) Direct detection of tRNAs in rNef/eEF1A
complexes in MDMs treated with rNef. Lysates from MDMs treated with rNef (100 ng/ml) for 3 h or left untreated (mock) were prepared, immunoprecipitated with anti-eEF1A
and anti-Nef antibodies, and tRNALys in the eEF1A/rNef complexes was amplified by RT-PCR. Lysates were also immunoprecipitated with an isotype control antibody.
The presence of HIV-1 Nef protein in the immune complex was determined by western blot. As an internal control, lysates fromMDMs treated with rNef (100 ng/ml) for 3 h were
prepared, treated with RNAse A (10 mg/ml) for 30min, immunoprecipitated with an anti-eEF1A antibody, and tRNALys in the eEF1A/Nef complexes was amplified by RT-PCR.
(b) Binding of tRNA to cytochrome c is eEF1A dependent. MDMs were mock treated or treated with BFA (10 mg/ml) or BFA (10 mg/ml)þNef (1000 ng/ml) for 12 h in the
presence of control or eEF1A siRNA. The lysates were immunoprecipitated with anti-cytochrome c, and presence and amount of tRNALys were determined by qRT-PCR and
further samples were resolved on 3% agarose gel and stained with EtBr. (c and d) MDMs were treated with recombinant Nef (100 ng/ml); the lysates were immunoprecipitated
with an anti-Nef Ab (c) or anti-eEF1A Ab (d) and the presence of tRNAMet, tRNALys, tRNATrp, and tRNAPhe in the Nef/eEF1A complex was determined by qRT-PCR.
(e and f) MDMs were treated with BFA for 12 h in the presence or absence of rNef (0–1500ng/ml); the lysates were immunoprecipitatedwith an anti-eEF1AAb (e) or anti-cytochrome
c Ab (f) and the presence of tRNAMet, tRNALys, tRNATrp, and tRNAPhe was determined by qRT-PCR. (g and h) The presence of tRNAs associated with eEF1A and
cytochrome c in BFA-stimulated MDMs treated with rNef is dependent on Exp-t. MDM cultures were transfected with a scrambled control siRNA, Exp-t siRNA, Exp-1 siRNA, or
Exp-5 siRNA. Cytoplasmic extracts of MDMs treated with BFA (10 mg/ml) for 12 h in the absence or presence of rNef (1000 ng/ml) were prepared 48 h post transfection,
immunoprecipitated with an anti-eEF1A Ab (g) or anti-cytochrome c Ab (h), and the presence of tRNALys, tRNAMet, tRNAPhe, and tRNATrp binding to eEF1A and
cytochrome c was determined by qRT-PCR. Results representative of three independent experiments are shown. *Po0.05. (i) The presence of tRNAs associated with
cytochrome c in BFA-stimulated MDMs treated with rNef is dependent on eEF1A. MDM cultures were transfected with control siRNA or eEF1A siRNA. Cytoplasmic extracts of
MDMs treated with BFA (10 mg/ml) for 12 h in the absence or presence of rNef (1000 ng/ml) were prepared 48 h post transfection and were immunoprecipitated with an
anti-cytochrome c Ab. The presence of tRNAMet, tRNALys, tRNAPhe, and tRNATrp binding to cytochrome c was determined using qRT-PCR. Results representative of two
independent experiments are shown
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Materials and Methods
Cell culture. Primary human MDMs were prepared from the peripheral blood
of healthy donors and cultured in RPMI medium supplemented with 10% (v/v)
pooled AB human serum (Sigma, Munich, Germany), as described previously.39
PBLs were cultivated in RPMI medium supplemented with 10% (v/v) fetal bovine
serum (FBS). Vero cells, MRC5 cells, and promonocytic U937 cells were obtained
from the American Tissue Cell Culture Collection (ATCC, Manassas, VA, USA).
The cell lines were cultivated in RPMI 1640 supplemented with 10% FBS, 1%
glutamine, and 1% penicillin/streptomycin.
Recombinant Nef treatment. MDMs (5 106 cells) were treated with
recombinant myristoylated Nef protein (rNef) from Jena Bioscience (Jena,
Germany). Cell pellets were collected at various times after treatment, washed
extensively, and either lysed for western blot analysis or fixed with 3%
paraformaldehyde in PBS for 30min for the TUNEL assay in flow cytometric
analysis. The bacterially expressed GST-Nef(WT), GST-Nef(1-60) and GST-
Nef(55-206) were purified and cleaved with thrombin (cat# 27-0846-01 GE
Healthcare Ltd., Little Chalfont, UK) according to the instruction provided by the
manufacturer. SDS-tricine polyacrylamide gel electrophoresis (PAGE) and
coomassie staining was done to visualize the thrombin cleaved products of
HIV-1Nef wild type and mutants.
Isolation of nuclear and cytoplasmic extracts. Nuclear and
cytoplasmic extracts were isolated as described previously.39 Cells were scraped
from the plastic surface of the culture dishes and washed with wash buffer (10mM
HEPES pH 7.6, 10mM KCl, 2 mM MgCl2, 1 mM EDTA). Cell pellets were
incubated on ice with cytoplasmic isolation buffer (10mM HEPES pH 7.6, 10mM
KCl, 2 mM MgCl2, 1mM EDTA, 0.02% Nonidet P-40). Supernatants containing
cytoplasmic extracts were collected by centrifugation leaving the nuclear pellets.
The pellets were washed twice in wash buffer, spun, and incubated for 15min on
ice with nuclear isolation buffer (20mM HEPES pH 7.6, 420 mM NaCl, 1.5 mM
MgCl2, 0.2 mM EDTA, 25% glycerol). Supernatants containing nuclear extracts
were collected by centrifugation and stored at  80 1C. Protease inhibitors (1 mM
DTT, 1mM PMSF, 1 mg/ml aprotinin, 1 mg/ml leupeptin, 1 mg/ml pepstatin) were
added to all solutions. Protein concentrations in the nuclear and cytoplasmic
extracts were determined by the Bradford method using a BioPhotometer
(Eppendorf, Hamburg, Germany).
Preparation of cytosolic and mitochondrial fractions. Cytosolic
and mitochondrial fractions were prepared using the cell fractionation kit-standard
(#MS861, Mitosciences, Eugene, OR, USA). The coxIV (Cell Signaling Technology,
Danvers, MA, USA) antibody was used as a mitochondrial loading control.
Immunoprecipitation. Vero cells, MRC5 cells, U937 cells, PBLs, or primary
MDMs were left untreated or treated with rNef for different periods of time. Cell
lysates were precleared by adding 50 ml of Protein G Plus/Protein A-Agarose
(Calbiochem-Novabiochem, Bad Soden, Germany) for 1 h at 4 1C. The cleared
supernatants were removed, combined with 5 mg anti-Nef or anti-EF1A antibodies
(Chemicon, Upstate, Billerica, MA, USA), and incubated overnight at 4 1C.
Immune complexes were washed in the presence of protease inhibitors, the bound
proteins eluted with sample buffer, and the proteins run on a 10% SDS-PAGE gel.
SDS-PAGE and western blot analysis were performed according to standard
procedures. Beta-actin and TATA-binding protein (TBP) (Sigma, St. Louis, MO,
USA) were used as cytoplasmic or nuclear loading controls, respectively. Western
blots were developed using the ECL detection kit (Amersham Pharmacia
Biotech, Little Chalfont, UK).
Plasmids and construction of expression vectors. Deletion
constructs were generated by standard PCR and cloning procedures.40 HIV-1
Nef constructs were verified by DNA sequencing. eEF1A/Nef interactions were
detected in vivo by transient co-transfection of GAL4-Nef and VP16-eEF1A in the
context of a mammalian two-hybrid system (CheckMate, Promega, Madison, WI,
USA). Sequence authenticity was confirmed by DNA cycle sequencing.
HIV-1 Nef wild type, N-terminus (1-60), or C-terminus (55–206) was cloned into
pGEX-4T-1 expression vector. For protein purification purposes, each construct
was transformed into bacteria (BL21DE from Novagen, Madison, WI, USA).
A single colony was inoculated in 5ml LB broth plus 50 mg/ml ampicillin at 37 1C in
a shaker overnight. A 1-ml aliquot of the overnight bacterial culture was used to
inoculate 300ml LB broth plus 50mg/ml ampicillin and grown for 2.5 h at 37 1C in a
shaker (until OD600¼ 0.5). IPTG was added at a final concentration of 0.1 mM
and the culture grown for an additional 3 h at 37 1C in the shaker. Bacteria were
pelleted, washed with ice-cold TBS, and lysed in bacterial protein extraction
reagents (Pierce, Rockford, IL, USA). eEF1A and mutants (kindly provided by Dr.
A Cimarelli, ENS-L, Lyon, France) were constructed and expressed in the
bacteria, as described previously.24
Transfection assay. To carry out transient transfections, the DNA
concentration was kept constant in the different samples by using the
corresponding empty vector. A total of 5 106 cells were transfected with
5–10mg total plasmid DNA, which included the firefly luciferase-expressing vector
using the DEAE-dextran procedure. Luciferase activity in cell lysates was
measured 48 h post transfection using a luminometer (TD-20/20, Promega).
Luciferase expression was normalized with respect to protein concentration using
the Detergent-Compatible Protein Assay (Bio-Rad, Munich, Germany). All
transfections were performed in triplicate.
Pull-down assays. Fragments of the cDNA encoding HIV-189.6 Nef were
produced using convenient restriction enzymes and PCR methods and then
cloned into the glutathione S transferase (GST) fusion vector pGEX-4T-1
(Amersham Biosciences, Little Chalfont, UK). The GST constructs (Nef[1-60] and
Nef[55-206]) kindly provided by Dr. Fackler (University of Heidelberg, Germany)
were transformed into the E. coli strain BL21 (Stratagene, La Jolla, CA, USA), and
the GST fusion proteins were purified according to the manufacturer’s instructions.
For pull-down assays, 20mg of the GST–Nef proteins (NefWT, Nef[1–60], Nef[55–
206]) were incubated overnight at 4 1C with 1500mg of MDM lysates. The
suspension was then washed three times in PBS, denaturized, and subsequently
separated by SDS-PAGE before autoradiography.
RNA interference. MDM cultures (0.5 106 cells) were transfected with a
scrambled control, Exp-t siRNA, Exp-1 siRNA, Exp-5 siRNA duplex (Santa Cruz
Biotechnology, Santa Cruz, CA, USA) or eEF1A siRNA (Dharmacon, Lafayette,
CO, USA) using Lipofectamine RNAiMAX (Invitrogen, Carlsbad, CA, USA). MDMs
were treated with rNef 48 h post transfection, and eEF1A, rNef, Exp-t, Exp-1, and
Exp-5 protein expression and MDM apoptosis were analyzed by western blot and
the annexin-V (Invitrogen) assay, respectively. Transfection efficiency was
monitored using a fluorescein-conjugated scrambled control duplex, exceeding
80% in MDMs.
tRNA interaction with cytochrome c, eEF1A, or Nef. To examine
the tRNA/cytochrome c interaction in vivo, MDMs transfected with Exp-t siRNA,
Exp-1 siRNA, Exp-5 siRNA, eEF1A siRNA or scramble siRNA for 48 h before
treatment with rNef were harvested and washed twice with ice-cold PBS. The
cytoplasmic extracts were immunoprecipitated with anti-cytochrome c antibody
(Santa Cruz Biotechnology) at 4 1C overnight followed by incubation with protein G
agarose beads for an additional 2 h. The beads were washed and resuspended in
200ml RNA elusion buffer (50mM Tris, 100 mM NaCl, 10mM EDTA, 0.1% SDS)
at 65 1C for 10min. RNA was extracted (RNeasy kit, Qiagen, Valencia, CA, USA)
and cDNA synthesized using a cDNA synthesis kit (Invitrogen).
The sequence of the primers (Eurogentec, Seraing, Belgium) used in RT-PCR
amplification were as follows:
tRNAMet forward 50-CTGGGCCCATAACCCAGAG-30
tRNAMet reverse 50-TAGCAGAGGATGGTTTCGAT-30
tRNATrp forward 50-GGCTCGTTGGTCTAGGGGTA-30
tRNATrp reverse 50-GATTTGAACCCGGGACCT-30
tRNAPhe forward 50-CCTCCTCAAAGCAATACACTGA-30
tRNAPhe reverse 50-GGTGATGTGAGCCCGTCTAA-30
tRNALys forward 50-ATAGCTCAGTCGGTAGAGCATCA-30
tRNALys reverse 50-ACAGGGACTTGAACCCTGGAC-30
The tRNAs associated with eEF1A, rNef and cytochrome c were detected after
immunoprecipitation with an anti-eEF1A and anti-cytochrome c or anti-Nef antibody,
followed by RT-PCR amplification as described above. Ct values were analyzed
using the DDCt method.41 DCt was calculated by normalization to the isotype
control, and DDCt values were calculated by normalizing to the Ct values of the
untreated sample. The DDCt values were also determined separately for untreated
cells and averaged around 1 (Supplementary Figure 2).
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Detection of apoptosis. The detection of apoptosis by the annexin-
V–propidium iodide assay (Invitrogen) and TUNEL assay (AbD Serotec, Oxford, UK)
was performed as previously described.28 For ER stress agents, an appropriate
dose was selected from a range of concentrations tested. BFA (Sigma), TG
(Sigma) and TM (Sigma) were used at 10 mg/ml.
Caspase activity. Caspase-9 and caspase-3 activity was measured by
western blotting as described previously.30 Where specified, protein levels were
quantified by densitometry using ImageJ 1.40 software (National Institutes of
Health, Bethesda, MA, USA).
Statistical analysis. Statistical analyses were performed using the analysis
of variance (ANOVA) test, and differences were considered significant at a value
of *Po0.05, **Po0.01, ***Po0.001. Microsoft Excel was used to construct the
plots.
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